For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Tlc Biopharmaceuticals, Inc.

USPTO Granted Patents = 32

% Expired Patents = 6.3

EPO Patents = 10

Forward Citations = 24

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Keelung Hong (23 out of 54 patents)

Yun-Long Tseng (22 out of 24 patents)

Sheue-Fang Shih (15 out of 17 patents)

4. Luke S S Guo (14 out of 15 patents)

5. Po-Chun Chang (13 out of 17 patents)

6. Chih-Chiang Tsai (6 out of 7 patents)

7. Pei Kan (5 out of 12 patents)

8. Yi-yu Lin (5 out of 6 patents)

9. Hao-wen Kao (5 out of 6 patents)

10. Hao-Wen Kao (4 out of 4 patents)

11. Yi-Yu Lin (4 out of 4 patents)

12. Hong-Hui Lin (4 out of 5 patents)

13. Walter Gwathney (4 out of 4 patents)

14. Chun-yen Lai (3 out of 4 patents)

15. Yung-Hsu Chan (3 out of 3 patents)

Core Competencies:

Sustained-Release

Pharmaceutical Composition

Liposomal Delivery

Corticosteroid

Anesthetic

Immunomodulating Agent

Tripatan

Camptothecin Derivatives

Ophthalmic Drug Delivery

Anti-VEGF

Pain Control

Therapeutic Agent

32 patents: Sort by Forward Citations

1. 12629354 - Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof (2026-05-19),

2. 12599557 - Liposomal sustained-release compositions containing a therapeutic drug and use thereof (2026-04-14),

3. 12514820 - Pharmaceutical composition of intra-articular corticosteroid for pain control (2026-01-06),

4. 12419837 - Liposomal composition containing mild acidic active agent (2025-09-23),

5. 12409154 - Pharmaceutical compositions for use in treating pain (2025-09-09),

6. 12285524 - Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof (2025-04-29),

7. 12280043 - Sustained-release anesthetic compositions and methods of preparation thereof (2025-04-21),

8. 12274785 - Sustained-release pharmaceutical compositions comprising an immunomodulating agent and uses thereof (2025-04-14),

9. 12268781 - Sustained-release pharmaceutical compositions comprising a therapeutic agent for treating dementia and uses thereof (2025-04-08),

10. 12208104 - Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain (2025-01-28),

11. 12083138 - Methods to reduce complications of intra-articular steroid (2024-09-10),

12. 11938220 - Sustained-release anesthetic compositions and methods of preparation thereof (2024-03-26),

13. 11793799 - Sustained-release anesthetic compositions and methods of preparation thereof (2023-10-24),

14. 11793755 - Pharmaceutical composition for intraarticular delivery (2023-10-24),

15. 11771766 - Drug delivery system containing phospholipid and cholesterol (2023-10-03),

Company Overview

Tlc Biopharmaceuticals, Inc. is a biopharmaceutical company based in South San Francisco, California, specializing in the development of innovative therapies for unmet medical needs. The organization focuses on advancing treatments in areas such as oncology and autoimmune diseases, leveraging cutting-edge research and technology to create effective solutions. With a commitment to improving patient outcomes, Tlc Biopharmaceuticals aims to bring transformative therapies from the lab to the clinic, addressing critical health challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

32 Patents

#45 in South San Francisco, CA

#2,535 in California

#10,607 in US

#20,697 in the World

South San Francisco, CA, United States of America

Tlc Biopharmaceuticals, Inc.

Forward Citations = 24

37 inventors:

Keelung Hong (23 out of 54 patents)

Yun-Long Tseng (22 out of 24 patents)

Sheue-Fang Shih (15 out of 17 patents)

4. Luke S S Guo (14 out of 15 patents)

5. Po-Chun Chang (13 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tlc Biopharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/tlc-biopharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…